Nortopixantrone hydrochloride

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameNortopixantrone hydrochloride
Drug Alias Name诺托生琼nortopixantronum诺托蒽醌nortopixantronanortopixantrone +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA inhibitorsTopoisomerase II inhibitors
TargetsTopoisomerase IIDNA
Therapy Area/IndicationsProstatic NeoplasmsOvarian NeoplasmsStomach Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNovusUniversity Of Vermont
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovusUniversity Of Vermont
Active IndicationsN/A
Inactive IndicationsProstatic NeoplasmsOvarian NeoplasmsStomach Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A